1-[(4R)-3-[7H-cyclopenta[b]pyridin-4-yl(methyl)amino]-4-methylpiperidine-1-carbonyl]azetidine-3-carbonitrile
C20H25N5O — CID 143251821
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[(4R)-3-[7H-cyclopenta[b]pyridin-4-yl(methyl)amino]-4-methylpiperidine-1-carbonyl]azetidine-3-carbonitrile
1-[(4R)-3-[7H-cyclopenta[b]pyridin-4-yl(methyl)amino]-4-methylpiperidine-1-carbonyl]azetidine-3-carbonitrile (PubChem CID 143251821) has the molecular formula C20H25N5O and a molecular weight of 351.45 g/mol. Its IUPAC name is 1-[(4R)-3-[7H-cyclopenta[b]pyridin-4-yl(methyl)amino]-4-methylpiperidine-1-carbonyl]azetidine-3-carbonitrile.
Molecular Properties
| Compound Name | 1-[(4R)-3-[7H-cyclopenta[b]pyridin-4-yl(methyl)amino]-4-methylpiperidine-1-carbonyl]azetidine-3-carbonitrile |
|---|---|
| PubChem CID | 143251821 |
| Molecular Formula | C20H25N5O |
| Molecular Weight | 351.45 g/mol |
| Exact Mass | 351.21 |
| IUPAC Name | 1-[(4R)-3-[7H-cyclopenta[b]pyridin-4-yl(methyl)amino]-4-methylpiperidine-1-carbonyl]azetidine-3-carbonitrile |
| SMILES | C[C@@H]1CCN(C(=O)N2CC(C#N)C2)CC1N(C)c1ccnc2c1C=CC2 |
| InChI | InChI=1S/C20H25N5O/c1-14-7-9-24(20(26)25-11-15(10-21)12-25)13-19(14)23(2)18-6-8-22-17-5-3-4-16(17)18/h3-4,6,8,14-15,19H,5,7,9,11-13H2,1-2H3/t14-,19?/m1/s1 |
| InChIKey | ZLDHSGPWSJOQNQ-MJTSIZKDSA-N |
| XLogP | 2.37 |
| TPSA | 63.47 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 351.45 |
| LogP ≤ 5 | 2.37 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143251821 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.